GlaxoSmithKline plc (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 165   

Articles published

GSK 46.59 +0.28 (0.60%)
price chart
GlaxoSmithKline plc (ADR) to Close Its Pittsburgh Office As It Consolidates ...
GlaxoSmithKline plc (ADR) (NYSE: GSK), is to close its Pittsburgh office in Moon Township, with the loss of up to 275 jobs at its Consumer Health Unit.
GlaxoSmithKline plc (ADR) And Novartis AG (ADR) Complete Three-Part Deal ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) and Novartis AG (ADR) (NYSE:NVS) announced on Monday that the two companies have completed a series of complicated asset swaps worth $20 billion, in what appears to be a move to tidy up asset portfolios to ...
Asset Swaps Of Novartis AG (ADR) (NYSE:NVS) and GlaxoSmithKline plc (ADR ...  Stocks.org
GlaxoSmithKline plc (ADR) (NYSE:GSK) CEO Andrew Witty's Pay Cut By 46%  InvestCorrectly
GlaxoSmithKline plc (ADR) Considers Changes To Its US Sales Staff ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) has been undergoing a seemingly rough patch in its US operations over the past year.
GlaxoSmithKline plc (ADR) ViiV Spinoff
Despite reporting troubled earnings and revenues Wednesday, GlaxoSmithKline plc ADR (NYSE:GSK) has been on an uptrend, after announcing various growth plans to stabilize the business.
GlaxoSmithKline plc (ADR) Announces $0.70 Quarterly Dividend (GSK)  Mideast Time
GlaxoSmithKline plc Receives Underweight Rating from JPMorgan Chase & Co ...  sleekmoney
GlaxoSmithKline plc (ADR) (GSK) In The Green After UBS Upgrades Stock To ...
Shares of GlaxoSmithKline Plc (ADR) (NYSE:GSK)�the world's leading research-based pharmaceutical company�are in the green today after UBS, the Swiss global financial services company, upgraded it from a �Sell� to a �Buy.
GlaxoSmithKline plc (ADR), Merck & Co., Inc., Pfizer Inc., Sanofi SA (ADR ...
Home > GlaxoSmithKline plc (ADR), Merck & Co., Inc., Pfizer Inc., Sanofi SA (ADR): Are Big Pharma Stocks In Trouble?
GlaxoSmithKline plc (ADR) Asthma Drug Wins Green Signal From FDA Panel ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) and Theravance Inc's (NASDAQ:THRX) respiratory medication Breo Ellipta for chronic obstructive pulmonary disease (COPD) won backing of a US Food and Drug Administration (FDA) advisory panel on Thursday, ...
Critical inspection of GlaxoSmithKline plc (ADR) (NYSE:GSK) by FDA ...  WallStreet.org
GlaxoSmithKline plc (ADR) Acquires Vaccine Maker GlycoVaxyn For $190 Million
GlaxoSmithKline Plc (ADR) (NYSE:GSK) announced Wednesday morning that it is acquiring the specialist Swiss vaccine maker, GlycoVaxyn, in a $190 million deal.
Novartis AG (ADR), GlaxoSmithKline plc (ADR) Recieve Final Approval For Thee ...
According to the US Federal Trade Commission's (FTC) announcement yesterday, Novartis (NYSE:NVS) has received the US antitrust regulator's approval to acquire drugs from Glaxo's oncology portfolio, contingent upon certain specified conditions.
GlaxoSmithKline plc (ADR) To Close Asset Swap Deal With Novartis AG (ADR ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) announced on Wednesday that it anticipates closing the mega-billion dollar asset exchange with Novartis AG (ADR) (NYSE:NVS) in the week beginning March 2, 2015.
Healthcare Stocks Traders Alert - GlaxoSmithKline (GSK), Pharmacyclics (PCYC ...  Techsonian (press release)
Novartis AG (NYSE:NVS) & GlaxoSmithKline PLC (NYSE:GSK) Receive a Green ...  WallStreet.org